Literature DB >> 25842774

Nutrition in cancer patients.

Renata Dobrila Dintinjana, Arnela Redzović, Aleksandar Cubranić, Marijan Dintinjana, Nenad Vanis.   

Abstract

Cachexia is defined as an unintended loss of stable weight exceeding 10%. Patients with advanced cachexia express anorexia, early satiety, severe weight loss, weakness, anemia, and edema. Anorexia represents the result of a failure of the usual appetite signals whereas cachexia is the debilitating state of involuntary weight loss. This syndrome, referred to as the cancer anorexia-cachexia syndrome, (CACS) and usually consists of a combination of anorexia, tissue wasting, malnutrition, weight loss and loss of compensatory increase in feeding. CACS represents the result of a complex interaction between cancer growth and host response and is associated with a poor response to chemotherapy and with an increase in drug-related toxicity. In advanced cachexia (mostly in metastatic cancer and terminally disease) any interventions with nutritional suplements are ineffective. Therefore, nutritional support in the reversion of tumor cachexia and in the importance of maintaining patient weight, muscle mass, quality of life, has the exceptional importance, becouse good nutritional status of patients leads to the possibility of more aggressive and longer treatment and thus to longer survival.

Entities:  

Mesh:

Year:  2014        PMID: 25842774

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  2 in total

1.  Stool Elastase as an Independent Prognostic Factor in Patients with Pancreatic Head Cancer.

Authors:  Honam Hwang; Hongbeom Kim; Hee Ju Sohn; Mirang Lee; Hyeong Seok Kim; Youngmin Han; Wooil Kwon; Jin-Young Jang
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

2.  Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.

Authors:  Juan Enrique Domínguez-Muñoz; Laura Nieto-Garcia; Javier López-Díaz; Jose Lariño-Noia; Ihab Abdulkader; Julio Iglesias-Garcia
Journal:  BMC Cancer       Date:  2018-05-05       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.